biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs

<< Previous

Bullboard Posts

Next >>

Post by ronrydellon Jan 23, 2023 11:53am

221 Views

Post# 35239916

New Buying Opportunity for Bioasis shareholder

One positive thing about this company now is that because of all the information in the Bioasis circular that all the shareholders got....plus the opportunity to buy, in 100K increments more of this stock we could pay the small amount (750K and 350K), slash more burn rate cash and sell out for a price of $.20 to $1.00 and still ensure that xB3 is still part of the deal.

I bought shares today at $..03 American, based on hopes that J@J would renew their option.

Comments?

<< Previous

Bullboard Posts

Next >>

Sirios Resource discovers visible gold in Quebec